---
title: "Immuron soars nearly 50% in regular trading on US deal for PROIBS"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/298064621.md"
description: "Shares jumped nearly 50% after Immuron secured exclusive US distribution rights for PROIBS in a deal with Calmino."
datetime: "2026-09-04T17:55:46.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/298064621.md)
  - [en](https://longbridge.com/en/news/298064621.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/298064621.md)
generator: "portal-rs"
---

# Immuron soars nearly 50% in regular trading on US deal for PROIBS

Immuron(IMRN.US) 盘中涨近 50%，现报 1.66 美元。

公司宣布与 Calmino 达成 PROIBS 产品的美国独家分销协议，推动股价大幅攀升。该消息在医疗板块引发关注，日内该股成交量显著放大。

### Related Stocks

- [IMRN.US](https://longbridge.com/en/quote/IMRN.US.md)

## Related News & Research

- [Immuron To Launch PROIBS In U.S. After Australia Debut; Pre-market Shares Up](https://longbridge.com/en/news/298028882.md)
- [Immuron to launch PROIBS® in the United States | IMRN Stock News](https://longbridge.com/en/news/298022732.md)
- [Immuron FY26 net sales rise 6% to AUD 7.7 million](https://longbridge.com/en/news/297303231.md)
- [Immuron posts CEO presentation for TechKnow Invest Roadshow](https://longbridge.com/en/news/293928783.md)
- [Immuron Stock Surges Friday: What's Driving the Action?](https://longbridge.com/en/news/298044643.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**